DNTH Dianthus Therapeutics

• None no insider bought on the open market
• None no sales outside a trading plan
• $71.2M sold by 8 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Edward Carr Chief Accounting Officer
   Planned sale
   $2M 20,000 shares at $101.38 100% of stake
   Traded Sep 17 Filed Sep 18
   ↗
3. Simrat Randhawa EVP, Head of R&D
   Planned sale
   $2.5M 23,124 shares at $106.41 85% of stake
   Traded Sep 1 Filed Sep 3
   ↗
4. Simon Read Director
   Planned sale
   $327K 2,778 shares at $117.55 100% of stake
   Traded Aug 19 Filed Aug 19
   ↗
5. Anne McGeorge Director
   Planned sale
   $845K 7,750 shares at $109.01 100% of stake
   Traded Aug 10 Filed Aug 11
   ↗
6. Adam M Veness SVP, General Counsel and Sec.
   Planned sale
   $2.2M 20,000 shares at $110.44 100% of stake
   Traded Aug 7–10 Filed Aug 11
   ↗
7. Simon Read Director
   Planned sale
   $304K 2,777 shares at $109.55 100% of stake
   Traded Aug 10 Filed Aug 11
   ↗
8. Marino Garcia CEO
   Planned sale
   $17.9M 166,000 shares at $108.11 72% of stake
   Traded Aug 7 Filed Aug 7
   ↗
9. Ryan Savitz CFO
   Planned sale
   $3.2M 31,249 shares at $101.03 100% of stake
   Traded Jul 9 Filed Jul 13
   ↗
10. Adam M Veness SVP, General Counsel and Sec.
    Planned sale
    $2.4M 30,000 shares at $80.80 100% of stake
    Traded Jun 17 Filed Jun 18
    ↗
11. Simrat Randhawa EVP, Head of R&D
    Planned sale
    $2.4M 26,530 shares at $90.62 87% of stake
    Traded Jun 1 Filed Jun 2
    ↗
12. Paula Soteropoulos Director
    Planned sale
    $51K 599 shares at $85.47 100% of stake
    Traded May 8 Filed May 11
    ↗
13. Ryan Savitz CFO
    Planned sale
    $739K 8,224 shares at $89.84 100% of stake
    Traded Apr 9 Filed Apr 10
    ↗
14. Ryan Savitz CFO
    Planned sale
    $9.5M 114,367 shares at $83.00 100% of stake
    Traded Mar 31 Filed Apr 1
    ↗
15. Paula Soteropoulos Director
    Planned sale
    $48K 599 shares at $80.11 100% of stake
    Traded Mar 31 Filed Apr 1
    ↗
16. Paula Soteropoulos Director
    Planned sale
    $2.2M 27,594 shares at $78.05 100% of stake
    Traded Mar 24 Filed Mar 26
    ↗

Also filed in the last 12 months, not counted as buying or selling: 41 option exercises.